image du produit
Lancet Oncology, The

S'abonner

Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines - 02/09/20

Doi : 10.1016/S1470-2045(20)30320-X 
Sumit Gupta, PhD a, ⁎, † , Joanne Aitken, ProfPhD b, †, Ute Bartels, ProfMD a, Nickhill Bhakta, MD c, Mihaela Bucurenci, MD d, James D Brierley, ProfMB e, Beatriz De Camargo, ProfPhD f, Eric Chokunonga g, Jessica Clymer, MD h, Dana Coza, MD d, Chris Fraser, MD i, Soad Fuentes-Alabi, MD j, Gemma Gatta, ProfPhD k, Thomas Gross, MD l, Zsuzsanna Jakab, PhD m, Betsy Kohler, PhD n, Tezer Kutluk, ProfMD o, Florencia Moreno, PhD p, Kayo Nakata, MD q, Sari Nur, MD r, D M Parkin, MD s, t, Lynne Penberthy, PhD l, Jason Pole, PhD u, Jenny N Poynter, PhD v, Kathy Pritchard-Jones, ProfMB w, Oscar Ramirez, MD x, Lorna Renner, MD y, Eva Steliarova-Foucher, PhD t, Michael Sullivan, ProfMD z, Rajaraman Swaminathan, ProfPhD aa, Liesbet Van Eycken, MD ab, Tushar Vora, MD ac, A L Frazier, ProfMD h
a Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada 
b Cancer Council Queensland, Brisbane, QLD, Australia 
c Global Pediatric Medicine, St Jude Children’s Research Hospital, Memphis, TN, USA 
d Romanian National Child Cancer Registry, Constanta, Romania 
e Radiation Medicine Program, Princess Margaret Hospital, Toronto, ON, Canada 
f Research Centre, National Cancer Institute National Cancer Institute, Rio de Janeiro, Brazil 
g The Zimbabwe National Cancer Registry, Harare, Zimbabwe 
h Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA 
i Department of Oncology, Children’s Health Queensland Hospital, South Brisbane, QLD, Australia 
j Ayúdame a Vivir Medical Center, San Salvador, El Salvador 
k Istituto Nazionale dei Tumori, Milan, Italy 
l National Cancer Institute, National Institute of Health, Bethesda, MD, USA 
m Hungarian Childhood Cancer Registry, Semmelweis University, Budapest, Hungary 
n North American Association of Central Cancer Registries, Springfield, IL, USA 
o Department of Paediatric Oncology, Hacettepe University Faculty of Medicine and Cancer Institute, Ankara, Turkey 
p Argentina National Cancer Institute, Buenos Aires, Argentina 
q Cancer Control Centre, Osaka International Cancer Institute, Osaka, Japan 
r Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Jawa Barat, Indonesia 
s Nuffield Department of Population Health, University of Oxford, Oxford, UK 
t Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France 
u Pediatric Group of Ontario, Toronto, ON, Canada 
v Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA 
w University College London, London, UK 
x Centro Médico Imbanaco, Cali, Valle del Cauca, Colombia 
y University of Ghana School of Medicine, Accra, Ghana 
z Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia 
aa Cancer Institute (WIA), Chennai, Tamil Nadu, India 
ab Belgian Cancer Registry, Saint-Josse-ten-Noode, Belgium 
ac Tata Memorial Centre, Mumbai, Maharashtra, India 

*Correspondence to: Dr Sumit Gupta, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M5G 1X8, CanadaDivision of Haematology/OncologyThe Hospital for Sick ChildrenTorontoONM5G 1X8Canada

Summary

Population-based cancer registries (PBCRs) generate measures of cancer incidence and survival that are essential for cancer surveillance, research, and cancer control strategies. In 2014, the Toronto Paediatric Cancer Stage Guidelines were developed to standardise how PBCRs collect data on the stage at diagnosis for childhood cancer cases. These guidelines have been implemented in multiple jurisdictions worldwide to facilitate international comparative studies of incidence and outcome. Robust stratification by risk also requires data on key non-stage prognosticators (NSPs). Key experts and stakeholders used a modified Delphi approach to establish principles guiding paediatric cancer NSP data collection. With the use of these principles, recommendations were made on which NSPs should be collected for the major malignancies in children. The 2014 Toronto Stage Guidelines were also reviewed and updated where necessary. Wide adoption of the resultant Paediatric NSP Guidelines and updated Toronto Stage Guidelines will enhance the harmonisation and use of childhood cancer data provided by PBCRs.

Le texte complet de cet article est disponible en PDF.

Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Imprimer
Export

    Export citations

  • Fichier

    •

  • Contenu

    •

Vol 21 - N° 9

P. e444-e451 - septembre 2020 Retour au numéro
Article précédent Article précédent
  • Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
  • Lisa Bodei, Heiko Schöder, Richard P Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin, Kjell Öberg, Irvin M Modlin
| Article suivant Article suivant
  • The science of hope
  • Benjamin W Corn, David B Feldman, Isaiah Wexler

Déjà abonné à cette revue ?